Atlas Trials

Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors

Clinical trial NCT05531708 · WITHDRAWN

Trial details

NCT number
NCT05531708
Sponsor
Shanghai Pudong Hospital
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Mesothelin-positive Advanced Refractory Solid Tumors
Start date
2021-04-02
Primary completion
2025-04-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.